Literature DB >> 2119468

Immune-mediated mesangial cell injury--biosynthesis and function of prostanoids.

R A Stahl1, F Thaiss, S Kahf, W Schoeppe, U M Helmchen.   

Abstract

We studied the formation of cyclo-oxygenase products in a rat model of mesangial cell injury, in order to determine a possible role of prostaglandin E2 (PGE2), prostaglandin I2 (determined as 6-keto-PGF1 alpha and thromboxane A2 (TxA2) in immune-mediated glomerular disease. Selective immune-mediated mesangial cell injury was induced by i.v. administration of a rabbit anti-rat thymocyte antiserum (ATS). Intravenous ATS leads to immune deposits in the mesangium followed by mesangiolysis and the infiltration of polymorphonuclear granulocytes and monocytes. Glomerular TxB2 formation two hours (292 +/- 27 pg/mg/min) and 48 hours (396 +/- 69 pg/mg/min) following antibody was significantly (P less than 0.05) higher compared to animals receiving non-antibody rabbit IgG (TxB2: 2 hr 143 +/- 13; 48 hr 171 +/- 32 pg/mg/min). Treatment with cobra venom factor (CVF) and the reduction of glomerular monocyte infiltration inhibited the increase of glomerular TxB2 formation significantly. Depletion of granulocytes with a rabbit anti-rat granulocyte serum had no effect on glomerular prostanoid formation following ATS. Glomerular PGE2 and 6-keto PGF1 alpha production was not altered following ATS. Inulin clearance in rats with immune-mediated mesangial cell injury was significantly (P less than 0.001) lower at two hours (456 +/- 24 microliters/min/100 g body wt) and 48 hours (433 +/- 54 microliters/min/100 g body wt) compared to their corresponding control animals which were treated with non-antibody IgG (2 hr: 914 +/- 51; 48 hr: 694 +/- 79 microliters/min/100 g body wt).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2119468     DOI: 10.1038/ki.1990.196

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  9 in total

1.  Mesangial cell immune injury. Synthesis, origin, and role of eicosanoids.

Authors:  E A Lianos; B A Bresnahan; C Pan
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

2.  Upregulation of fibronectin expression by COX-2 is mediated by interaction with ELMO1.

Authors:  Chen Yang; Andrey Sorokin
Journal:  Cell Signal       Date:  2010-08-21       Impact factor: 4.315

3.  Increased excretion of soluble interleukin 2 receptors and free light chain immunoglobulins in the urine of patients with active lupus nephritis.

Authors:  C Y Tsai; T H Wu; K H Sun; W M Lin; C L Yu
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

4.  Platelet-complement interactions in mesangial proliferative nephritis in the rat.

Authors:  R J Johnson; P Pritzl; H Iida; C E Alpers
Journal:  Am J Pathol       Date:  1991-02       Impact factor: 4.307

5.  The commonly used beta-actin-GFP transgenic mouse strain develops a distinct type of glomerulosclerosis.

Authors:  Jian-Kan Guo; Ee-Chun Cheng; Lin Wang; E Scott Swenson; Thomas A Ardito; Michael Kashgarian; Lloyd G Cantley; Diane S Krause
Journal:  Transgenic Res       Date:  2007-06-27       Impact factor: 2.788

6.  Platelets and neutrophils are critical to the enhanced glomerular arachidonate metabolism in acute nephrotoxic nephritis in rats.

Authors:  X Wu; J Pippin; J B Lefkowith
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

7.  Mesangial cell immune injury. Hemodynamic role of leukocyte- and platelet-derived eicosanoids.

Authors:  B A Bresnahan; S Wu; F J Fenoy; R J Roman; E A Lianos
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

8.  Structural analysis of the formation of glomerular microaneurysms in the Habu venom model.

Authors:  S Uiker; W Kriz
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

9.  The expression of beta 1 integrin and intercellular adhesion molecule-1 on mesangial cells and its modulation in glomerulonephritis.

Authors:  C G Ihm; J P Kim; J K Park; B J Kim; J H Ahn; T W Lee; M H Yang; M J Kim
Journal:  Korean J Intern Med       Date:  1994-07       Impact factor: 2.884

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.